157 related articles for article (PubMed ID: 26687444)
1. Inclusion complexes of hydrochlorothiazide and β-cyclodextrin: Physicochemical characteristics, in vitro and in vivo studies.
Mendes C; Buttchevitz A; Kruger JH; Kratz JM; Simões CM; de Oliveira Benedet P; Oliveira PR; Silva MA
Eur J Pharm Sci; 2016 Feb; 83():71-8. PubMed ID: 26687444
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical composition of hydrochlorothiazide:β-cyclo-dextrin: preparation by three different methods, physico-chemical characterization and in vivo diuretic activity evaluation.
Pires MA; Souza Dos Santos RA; Sinisterra RD
Molecules; 2011 May; 16(6):4482-99. PubMed ID: 21623317
[TBL] [Abstract][Full Text] [Related]
3. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
[TBL] [Abstract][Full Text] [Related]
4. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
5. Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrin.
Ozdemir N; Ordu S
Drug Dev Ind Pharm; 1998 Jan; 24(1):19-25. PubMed ID: 15605593
[TBL] [Abstract][Full Text] [Related]
6. Preformulative assessment of preformed complexes of gemfibrozil, with cyclodextrins.
Ain S; Philip B; Pathak K
PDA J Pharm Sci Technol; 2008; 62(4):300-8. PubMed ID: 19174958
[TBL] [Abstract][Full Text] [Related]
7. Preparation and solid-state characterization of inclusion complexes formed between miconazole and methyl-beta-cyclodextrin.
Ribeiro A; Figueiras A; Santos D; Veiga F
AAPS PharmSciTech; 2008; 9(4):1102-9. PubMed ID: 18975116
[TBL] [Abstract][Full Text] [Related]
8. Preformulation study of the inclusion complex warfarin-beta-cyclodextrin.
Zingone G; Rubessa F
Int J Pharm; 2005 Mar; 291(1-2):3-10. PubMed ID: 15707726
[TBL] [Abstract][Full Text] [Related]
9. Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds.
Fernandes CM; Teresa Vieira M; Veiga FJ
Eur J Pharm Sci; 2002 Feb; 15(1):79-88. PubMed ID: 11803134
[TBL] [Abstract][Full Text] [Related]
10. Preparation & characterization of solid inclusion complex of cefpodoxime proxetil with beta-cyclodextrin.
Bhargava S; Agrawal GP
Curr Drug Deliv; 2008 Jan; 5(1):1-6. PubMed ID: 18220545
[TBL] [Abstract][Full Text] [Related]
11. Fosinopril-cyclodextrin inclusion complexes: phase solubility and physicochemical analysis.
Sbârcea L; Udrescu L; Drăgan L; Trandafirescu C; Szabadai Z; Bojiţă M
Pharmazie; 2011 Aug; 66(8):584-9. PubMed ID: 21901980
[TBL] [Abstract][Full Text] [Related]
12. Solubility and stability enhancement of atorvastatin by cyclodextrin complexation.
Palem CR; Patel S; Pokharkar VB
PDA J Pharm Sci Technol; 2009; 63(3):217-25. PubMed ID: 20069794
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization, and pharmacokinetics of the inclusion complex of genipin-beta-cyclodextrin.
Lu Y; Zhang T; Tao J; Ji G; Wang S
Drug Dev Ind Pharm; 2009 Dec; 35(12):1452-9. PubMed ID: 19929204
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of mosapride citrate inclusion complexes with natural and synthetic cyclodextrins.
Ali AA; Sayed OM
Pharm Dev Technol; 2013; 18(5):1042-50. PubMed ID: 22206481
[TBL] [Abstract][Full Text] [Related]
15. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
Jug M; Maestrelli F; Bragagni M; Mura P
J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
[TBL] [Abstract][Full Text] [Related]
16. Characterization and molecular modeling of the inclusion complexes of 2-(2-nitrovinyl) furan (G-0) with cyclodextrines.
Ruz V; Froeyen M; Busson R; González MM; Baudemprez L; Van den Mooter G
Int J Pharm; 2012 Dec; 439(1-2):275-85. PubMed ID: 22989977
[TBL] [Abstract][Full Text] [Related]
17. Triamterene-beta-cyclodextrin systems: preparation, characterization and in vivo evaluation.
Mukne AP; Nagarsenker MS
AAPS PharmSciTech; 2004 Mar; 5(1):E19. PubMed ID: 15198540
[TBL] [Abstract][Full Text] [Related]
18. Ternary complexation of carvedilol, beta-cyclodextrin and citric acid for mouth-dissolving tablet formulation.
Pokharkar V; Khanna A; Venkatpurwar V; Dhar S; Mandpe L
Acta Pharm; 2009 Jun; 59(2):121-32. PubMed ID: 19564138
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of etoricoxib-beta-cyclodextrin complexes prepared by the kneading method.
Patel HM; Suhagia BN; Shah SA; Rathod IS; Parmar VK
Acta Pharm; 2007 Sep; 57(3):351-9. PubMed ID: 17878114
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of inclusion complex of norflurazon and beta-cyclodextrin to improve herbicide formulations.
Villaverde J; Morillo E; Pérez-Martínez JI; Ginés JM; Maqueda C
J Agric Food Chem; 2004 Feb; 52(4):864-9. PubMed ID: 14969543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
